8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Jun 16, 2010)

Filed June 16, 2010For Securities:ELV

Summary

Elevance Health, Inc. (then operating as WellPoint, Inc.) issued this Form 8-K on June 16, 2010, to disclose that its officers intended to reaffirm the company's full-year 2010 earnings per share (EPS) guidance. This reaffirmation was to be communicated to securities analysts and investors during meetings scheduled between June 16 and June 30, 2010. The guidance, originally provided on April 28, 2010, was stated to include no net investment gains or losses or asset impairment charges beyond those recorded in the first quarter of 2010. However, the outlook remained contingent upon WellPoint's ability to secure and maintain sufficient premium rates, highlighting a key dependency for future financial performance. The filing also includes a comprehensive safe harbor statement, outlining numerous risks and uncertainties that could materially affect actual results, including regulatory changes (such as the Patient Protection and Affordable Care Act), healthcare cost trends, competitive pressures, and potential impacts from significant transactions like the Express Scripts deal.

Key Highlights

  • 1WellPoint, Inc. reaffirmed its full-year 2010 earnings per share (EPS) guidance.
  • 2The reaffirmation was communicated to securities analysts and investors during meetings from June 16 to June 30, 2010.
  • 3Full-year 2010 EPS guidance excludes net investment gains/losses or asset impairment charges beyond Q1 2010.
  • 4The company's financial outlook is subject to its ability to secure and maintain adequate premium rates.
  • 5The filing emphasizes that forward-looking statements are subject to significant risks and uncertainties.
  • 6Key risks mentioned include regulatory changes (Affordable Care Act), healthcare cost trends, and competitive pricing.
  • 7Potential impacts from the Express Scripts transaction are noted as a source of risk and uncertainty.

Frequently Asked Questions

The primary purpose of this Form 8-K filing was to formally disclose that WellPoint's officers intended to reaffirm the company's previously issued full-year 2010 earnings per share guidance during upcoming meetings with securities analysts and investors.

WellPoint reaffirmed its full-year 2010 EPS guidance. This guidance was stated to exclude any net investment gains or losses or asset impairment charges beyond those already recorded in the first quarter of 2010. The outlook was explicitly conditioned on WellPoint's success in securing and maintaining sufficient premium rates.

The filing highlighted numerous risks, including the impact of the Patient Protection and Affordable Care Act, trends in healthcare costs and utilization, the ability to secure adequate premium rates and regulatory approvals, competitive pressures, potential changes in enrollment mix, risks related to Medicare and Medicaid programs, financial strength ratings, litigation, the integration of the Express Scripts transaction, and general economic conditions.

No, this 8-K does not represent a change in financial performance. Instead, it serves to reaffirm existing guidance and inform the market about upcoming communications with analysts and investors regarding that guidance. The filing emphasizes that the forward-looking statements and guidance are subject to significant risks and uncertainties that could cause actual results to differ materially.